Quarterly report · Q3
2372.TEDINET S100Q33O
Period2022-04-01 → 2022-12-31
Filed2023-02-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.9bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥15.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.7bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥3.0bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥2.2bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.9bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.6bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.3bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥3.0bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.4bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥1.8bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥32.2bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥26.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥26.1bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥20.4bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥16.4bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.8bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥10.2bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.9bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.3bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.4bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥185.13 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.05 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥162.5 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥147.38 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥87.36 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥184.94 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥162.17 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥147.06 | 2021-04-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 36.7% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.7% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥104m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥58m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥46m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | −¥237m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥953m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥953m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥996m |
| jpcrp040300-q3r_E05352-000Advanced Medicalreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E05352-000Advanced Medicalreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E05352-000Advanced Medicalreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2m |
| jpcrp040300-q3r_E05352-000Advanced Medicalreportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥100m |
| jpcrp040300-q3r_E05352-000CROreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.1bn |
| jpcrp040300-q3r_E05352-000CROreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E05352-000CROreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥97m |
| jpcrp040300-q3r_E05352-000CROreportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥70m |
| jpcrp040300-q3r_E05352-000Medical Supportreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E05352-000Medical Supportreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥776m |
| jpcrp040300-q3r_E05352-000Medical Supportreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥691m |
| jpcrp040300-q3r_E05352-000Medical Supportreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥69m |
| jpcrp040300-q3r_E05352-000SMOreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥8.1bn |
| jpcrp040300-q3r_E05352-000SMOreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥8.0bn |
| jpcrp040300-q3r_E05352-000SMOreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥115m |
| jpcrp040300-q3r_E05352-000SMOreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥4.4bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥14.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥13.8bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥907m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥14.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥953m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-12-31 | ¥55m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥12m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥43m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-12-31 | −¥142m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥811m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥811m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥1.0bn |
| jpcrp040300-q3r_E05352-000Advanced Medicalreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥489m |
| jpcrp040300-q3r_E05352-000Advanced Medicalreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥486m |
| jpcrp040300-q3r_E05352-000Advanced Medicalreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥3m |
| jpcrp040300-q3r_E05352-000Advanced Medicalreportable segment | segment profit | 2021-04-01 → 2021-12-31 | −¥452m |
| jpcrp040300-q3r_E05352-000CROreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥3.8bn |
| jpcrp040300-q3r_E05352-000CROreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥3.7bn |
| jpcrp040300-q3r_E05352-000CROreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥50m |
| jpcrp040300-q3r_E05352-000CROreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥435m |
| jpcrp040300-q3r_E05352-000Medical Supportreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E05352-000Medical Supportreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥774m |
| jpcrp040300-q3r_E05352-000Medical Supportreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥589m |
| jpcrp040300-q3r_E05352-000Medical Supportreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥233m |
| jpcrp040300-q3r_E05352-000SMOreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥6.8bn |
| jpcrp040300-q3r_E05352-000SMOreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥6.7bn |
| jpcrp040300-q3r_E05352-000SMOreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥124m |
| jpcrp040300-q3r_E05352-000SMOreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥3.1bn |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥12.4bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥11.7bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥767m |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥3.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥12.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥811m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥3.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 416
| Item | Context | Value | Unit |
|---|---|---|---|
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income single statement (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |